Breaking News
Download App
:

Paracetamol, Pan D Among 53 Medicines Failing Quality Tests, Raising Safety Concerns

Image of a medical report highlighting the Central Drugs Standards Control Organisation's (CDSCO) announcement that over 50 medicines, including Paracetamol and Pan D, have been declared "Not of Standard Quality," raising serious safety concerns for consumers.

Paracetamol

The Central Drugs Standards Control Organisation (CDSCO) has declared more than 50 medicines, including Paracetamol, Pan D, and various calcium supplements, as "Not of Standard Quality" (NSQ) in its latest monthly quality check report. This alarming announcement raises serious safety concerns regarding these products.

In its August 2024 report, the CDSCO identified a range of medications—including Paracetamol, vitamin D and calcium supplements, high blood pressure treatments, and specific anti-diabetes medications—as part of the NSQ Alert category. These alerts arise from random monthly sampling conducted by state drug officers.

Among the 53 products that failed the quality check are vitamin C and D3 tablets, Shelcal, vitamin B complex, vitamin C softgels, the anti-acid Pan D, 500 mg Paracetamol tablets, the anti-diabetic drug Glimepiride, and the high blood pressure medication Telmisartan.

These medications are manufactured by various companies, including Hetero Drugs, Alkem Laboratories, Hindustan Antibiotics Limited (HAL), Karnataka Antibiotics & Pharmaceuticals Ltd, Pure & Cure Healthcare, and Meg Lifesciences. Notably, Metronidazole, a widely used treatment for stomach infections produced by HAL, also failed quality testing, alongside Shelcal, a popular calcium and vitamin D3 supplement flagged in the NSQ Alert category.

In addition, a Kolkata drug-testing lab has labeled antibiotics like Clavam 625 and Pan D as spurious. The lab also identified Hetero's Cepodem XP 50 Dry Suspension, commonly prescribed for children, as failing quality standards.

The CDSCO has issued two lists: one detailing 48 drugs that did not meet quality tests and another comprising 5 drugs in the NSQ Alert category, along with responses from their manufacturers. In one case, the manufacturer of Pulmosil stated that the questioned batch was not produced by them, indicating the possibility of spurious products.

The identification of Paracetamol among these 53 drugs raises critical safety concerns as consumers rely on these medications for their health needs.

Popular post

Latest post

You may also like

Subscribe Here

Enter your email address to subscribe to this website and receive notifications of new posts by email.

Join Us